{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T14:03:20Z","timestamp":1766757800535,"version":"3.48.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Well conducted, prospective, blood-based biomarker studies on dementia risk are growing, providing valuable insights into disease mechanisms that precede clinical symptoms. These investigations are crucial for advancing our understanding of dementia pathology and identifying early biological changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Emerging evidence shows that proteins detected in peripheral tissues and the circulatory system can also play a role in neurological diseases. Both neuronal and nonbrain-specific proteins have been associated with dementia prior to symptom onset, highlighting the complex and multisystem nature of disease development. Of the 11 studies included in this review that focused on prospective studies of dementia that applied plasma proteomics, 36 proteins were identified in at least two independent cohorts, suggesting that blood-based proteomics detects consistent protein levels that may be altered years before dementia diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Blood-based biomarkers hold promise for early diagnosis, patient stratification, and mechanistic research in dementia. The observed overlap in protein profiles across studies suggests we are beginning to uncover systemic biological differences that contribute to disease progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mol.0000000000001019","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T23:00:10Z","timestamp":1762383610000},"page":"14-26","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The current landscape of prospective proteomics research into dementia using blood-based samples"],"prefix":"10.1097","volume":"37","author":[{"given":"Josefine Tvermoes","family":"Meineche","sequence":"first","affiliation":[{"name":"Section of Epidemiology, Department of Public Health, Faculty of Health and Medical Sciences"},{"name":"Proteomics Research Infrastructure, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wierer","sequence":"additional","affiliation":[{"name":"Proteomics Research Infrastructure, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majken Karoline","family":"Jensen","sequence":"additional","affiliation":[{"name":"Section of Epidemiology, Department of Public Health, Faculty of Health and Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"R1-20251226","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"key":"R3-20251226","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s43587-021-00064-0","article-title":"Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk","volume":"1","author":"Walker","year":"2021","journal-title":"Nat Aging"},{"key":"R4-20251226","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cels.2016.02.015","article-title":"Plasma proteome profiling to assess human health and disease","volume":"2","author":"Geyer","year":"2016","journal-title":"Cell Syst"},{"key":"R5-20251226","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"R6-20251226","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev.pharmtox.41.1.347","article-title":"Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies","volume":"41","author":"Lesko","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R7-20251226","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the Lancet Standing Commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"key":"R8-20251226","first-page":"182","article-title":"Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma","volume":"6","author":"Koch","year":"2017","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"key":"R9-20251226","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol"},{"key":"R10-20251226","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"key":"R11-20251226","first-page":"1797","article-title":"Plasma p-tau231 and p-tau217 as state markers of amyloid-\u03b2 pathology in preclinical Alzheimer's disease","volume":"28","author":"Mil\u00e0-Alom\u00e0","year":"2022","journal-title":"Nat Med"},{"key":"R12-20251226","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","article-title":"The blood-brain barrier in aging and neurodegeneration","volume":"27","author":"Knox","year":"2022","journal-title":"Mol Psychiatry"},{"key":"R13-20251226","doi-asserted-by":"crossref","first-page":"2200013","DOI":"10.1002\/pmic.202200013","article-title":"Mass spectrometry-based high-throughput proteomics and its role in biomedical studies and systems biology","volume":"23","author":"Messner","year":"2023","journal-title":"Proteomics"},{"key":"R14-20251226","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/s41586-025-08584-0","article-title":"Mass-spectrometry-based proteomics: from single cells to clinical applications","volume":"638","author":"Guo","year":"2025","journal-title":"Nature"},{"key":"R15-20251226","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1021\/acs.jproteome.4c00411","article-title":"Crossing the halfway point: aptamer-based, highly multiplexed assay for the assessment of the proteome","volume":"23","author":"Kraemer","year":"2024","journal-title":"J Proteome Res"},{"key":"R16-20251226","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1038\/s41467-023-42834-x","article-title":"NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing","volume":"14","author":"Feng","year":"2023","journal-title":"Nat Commun"},{"key":"R18-20251226","doi-asserted-by":"crossref","first-page":"2100170","DOI":"10.1002\/pmic.202100170","article-title":"Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platforms","volume":"22","author":"Haslam","year":"2022","journal-title":"Proteomics"},{"key":"R19-20251226","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1021\/acs.jproteome.2c00838","article-title":"An introduction to mass spectrometry-based proteomics","volume":"22","author":"Shuken","year":"2023","journal-title":"J Proteome Res"},{"key":"R20-20251226","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature19949","article-title":"Mass-spectrometric exploration of proteome structure and function","volume":"537","author":"Aebersold","year":"2016","journal-title":"Nature"},{"key":"R22-20251226","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/s41591-024-03142-z","article-title":"Proteomic signatures improve risk prediction for common and rare diseases","volume":"30","author":"Carrasco-Zanini","year":"2024","journal-title":"Nat Med"},{"key":"R23-20251226","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/s43587-024-00693-1","article-title":"Serum proteomics reveal APOE-\u03b54-dependent and APOE-\u03b54-independent protein signatures in Alzheimer's disease","volume":"4","author":"Frick","year":"2024","journal-title":"Nat Aging"},{"key":"R24-20251226","doi-asserted-by":"crossref","first-page":"fcaf097","DOI":"10.1093\/braincomms\/fcaf097","article-title":"Unraveling the role of proteins in dementia: insights from two UK cohorts with causal evidence","volume":"7","author":"Gong","year":"2025","journal-title":"Brain Commun"},{"key":"R26-20251226","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/CIRCULATIONAHA.124.070454","article-title":"A Proteomics-based approach for prediction of different cardiovascular diseases and dementia","volume":"151","author":"Ho","year":"2025","journal-title":"Circulation"},{"key":"R27-20251226","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.1007\/s12035-025-04716-9","article-title":"Prospective investigation unravels plasma proteomic links to dementia","volume":"62","author":"Li","year":"2025","journal-title":"Mol Neurobiol"},{"key":"R28-20251226","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/alz.12419","article-title":"Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies","volume":"18","author":"Lindbohm","year":"2022","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"R29-20251226","doi-asserted-by":"crossref","first-page":"eadf5681","DOI":"10.1126\/scitranslmed.adf5681","article-title":"Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life","volume":"15","author":"Walker","year":"2023","journal-title":"Sci Transl Med"},{"key":"R30-20251226","doi-asserted-by":"crossref","first-page":"7817","DOI":"10.1038\/s41467-023-43575-7","article-title":"Plasma proteomic profiles predict individual future health risk","volume":"14","author":"You","year":"2023","journal-title":"Nat Commun"},{"key":"R31-20251226","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/s41380-024-02840-x","article-title":"Large-scale proteomic analyses of incident Alzheimer's disease reveal new pathophysiological insights and potential therapeutic targets","volume":"30","author":"Zhang","year":"2025","journal-title":"Mol Psychiatry"},{"key":"R32-20251226","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1093\/brain\/awaa342","article-title":"Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease","volume":"143","author":"Benedet","year":"2020","journal-title":"Brain"},{"key":"R33-20251226","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/jamaneurol.2018.3746","article-title":"Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders","volume":"76","author":"Olsson","year":"2019","journal-title":"JAMA Neurol"},{"key":"R34-20251226","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","article-title":"Neurofilament light chain","volume":"84","author":"Lu","year":"2015","journal-title":"Neurology"},{"key":"R37-20251226","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1038\/s43587-025-00965-4","article-title":"Plasma proteomic associations with Alzheimer's disease endophenotypes","volume":"5","author":"Afshar","year":"2025","journal-title":"Nat Aging"},{"key":"R38-20251226","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3390\/cells9051275","article-title":"SPON1 can reduce amyloid beta and reverse cognitive impairment and memory dysfunction in Alzheimer's disease mouse model","volume":"9","author":"Park","year":"2020","journal-title":"Cells"},{"key":"R39-20251226","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1073\/pnas.1216206110","article-title":"Genome-wide scan of healthy human connectome discovers SPON1 gene variant influencing dementia severity","volume":"110","author":"Jahanshad","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"R40-20251226","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N Engl J Med"},{"key":"R41-20251226","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.20160493","article-title":"Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?","volume":"213","author":"Stanley","year":"2016","journal-title":"J Exp Med"},{"key":"R42-20251226","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s40478-024-01823-x","article-title":"Altered brain expression and cerebrospinal fluid levels of TIMP4 in cerebral amyloid angiopathy","volume":"12","author":"J\u00e4kel","year":"2024","journal-title":"Acta Neuropathol Commun"},{"key":"R43-20251226","doi-asserted-by":"crossref","first-page":"8558","DOI":"10.1038\/s41598-020-65353-x","article-title":"The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes","volume":"10","author":"James","year":"2020","journal-title":"Sci Rep"},{"key":"R44-20251226","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1038\/s41588-025-02319-7","article-title":"A standardized framework for circulating blood proteomics","volume":"57","author":"Cai","year":"2025","journal-title":"Nat Genet"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOL.0000000000001019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T14:00:28Z","timestamp":1766757628000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOL.0000000000001019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0000000000001019","relation":{},"ISSN":["0957-9672","1473-6535"],"issn-type":[{"type":"print","value":"0957-9672"},{"type":"electronic","value":"1473-6535"}],"subject":[],"published":{"date-parts":[[2025,11,5]]}}}